Why is Alkem Lab falling/rising?

As of 09-Sep, Alkem Laboratories Ltd is currently priced at 5,337.60, reflecting an increase of 15.1 points or 0.28%. The stock has shown a positive performance over the past week with a return of +1.56%, although it has underperformed its sector by -0.35% today. Despite trading above its moving averages across various time frames, there has been a significant decline in investor participation, with delivery volume dropping by -74.83% compared to the 5-day average. While the company boasts a high return on equity (ROE) of 17.69% and a low debt-to-equity ratio, it has faced challenges with poor long-term growth, as evidenced by a net sales growth rate of only 9.38% over the last five years. Additionally, a decrease in promoter stake by -2.09% may indicate reduced confidence in the company's future prospects.
In the broader market context, Alkem Laboratories has outperformed the Sensex over the past week and month, with respective returns of +1.56% and +12.05%, compared to the Sensex's +1.18% and +1.56%. However, the stock has significantly underperformed the market over the past year, with a return of -14.62% against the BSE500's -2.87%. This disparity highlights the stock's struggles despite some positive short-term movements, suggesting that while there may be some optimism reflected in the current price increase, underlying concerns regarding long-term growth and promoter confidence continue to weigh on investor sentiment.